In the running medical fight over the therapeutic value of enzymes as natural catalysts (TIME, July 13), the leading spokesman for the affirmative fired off some new evidence last week. Dr. Irving Innerfield of New York Medical College told the Toledo Academy of Medicine that new methods of administering enzymes to patients are safer than the old, and no less effective in speeding recovery from a variety of diseases, including thrombophlebitis, diabetes, rheumatic fever, arthritis and acute eye infections.
The specific enzyme on which Dr. Innerfield has been working is trypsin, a secretion of the pancreas. In some situations, claims Dr....
To continue reading:
or
Log-In
